1. Neuroimaging Findings in Chronic Hepatitis C Virus Infection: Correlation with Neurocognitive and Neuropsychiatric Manifestations
    Matteo Tagliapietra et al, 2020, International Journal of Molecular Sciences CrossRef
  2. Critical View on the Usage of Ribavirin in Already Existing Psychostimulant-Use Disorder
    Branka Petković et al, 2020, Current Pharmaceutical Design CrossRef
  3. Gender, homelessness, hospitalization and methamphetamine use fuel depression among people who inject drugs: implications for innovative prevention and care strategies
    Lionel Moulis et al, 2023, Frontiers in Psychiatry CrossRef
  4. Distribution of hepatitis С virus drug resistance mutations among patients with recurrence of the disease during therapy with direct antiviral drugs
    D. E. Reingardt et al, 2024, HIV Infection and Immunosuppressive Disorders CrossRef
  5. Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted
    Pobitra Borah et al, 2021, Frontiers in Molecular Biosciences CrossRef
  6. Two Cases of Chronic Central Serous Chorioretinopathy Successfully Treated with Systemic Interferon Alpha
    Lingling Huang et al, 2023, Ocular Immunology and Inflammation CrossRef
  7. Viral hepatitis: A brief introduction, review of management, advances and challenges
    Olga Fagan et al, 2021, World Journal of Meta-Analysis CrossRef
  8. Neuropsychiatric Effects of Antiviral Drugs
    Nicholas Zareifopoulos et al, 2020, Cureus CrossRef
  9. COVID-19, interferons, and depression: A commentary
    Richard I. Shader, 2020, Psychiatry Research CrossRef
  10. Safety of Interferon Products: a Retrospective Analysis of Adverse Reactions Spontaneously Reported in the Republic of Crimea
    Alexander V. Matveev et al, 2021, Health, Food & Biotechnology CrossRef
  11. Research progress on pathogenic and therapeutic mechanisms of Enterovirus A71
    Jianmei Lai et al, 2023, Archives of Virology CrossRef
  12. Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders
    Dorota Dybowska et al, 2023, World Journal of Gastroenterology CrossRef